Related Experiment Video
Updated: Apr 15, 2026

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesis
Wenjie Zhang1, Jiajie Hou1, Xiaochen Wang1
1Liver Transplantation Center of The First Affiliated Hospital and State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, Jiangsu Province, P.R. China.
Abstract:
Autophagy plays a critical role in the progression of nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC). Protein tyrosine phosphatase receptor type O (PTPRO) was recently identified as a tumor suppressor, but little is known about its role in NASH. Here, we investigated the role of PTPRO-dependent autophagy in insulin resistance, lipid metabolism, and hepatocarcinogenesis. Wild-type (WT) and ptpro-/- mice were fed a high-fat diet (HFD) for another 16 weeks after diethylnitrosamine (DEN) injection to induce NASH. Ptpro-/- mice exhibited severe liver injury, insulin resistance, hepatosteatosis and autophagy deficiency compared with WT littermates. PTPRO deletion also promoted the induction of lipogenic target genes and decreases in β-oxidation-related genes. Increased activation of AKT and accumulation of cytoplasmic p53 was detected in ptpro-/- mice, which in combination repressed autophagy. Intriguingly, hyperinsulinemia involving AKT activation was also exacerbated in HFD-fed mice due to PTPRO deletion. Activation of AKT induced stabilization of the MDMX/MDM2 heterocomplex, thus promoting p53 accumulation in the cytoplasm. Inhibition of AKT restored autophagy and p53 accumulation in hepatocytes, indicating that AKT acts upstream of p53. Due to hyperinsulinemia and autophagy deficiency, a HFD could aggravate steatohepatitis in ptpro-/- mice. Importantly, the expression of PTPRO was much decreased in human steatohepatitis, which was associated with increased p62 accumulation. Together, these data indicate that PTPRO regulates insulin and lipid metabolism via the PI3K/Akt/MDM4/MDM2/P53 axis by affecting autophagy.
Insights
Protein tyrosine phosphatase receptor type O (PTPRO) deficiency worsens nonalcoholic steatohepatitis (NASH) by impairing autophagy and lipid metabolism, promoting liver injury and cancer via the PI3K/Akt/p53 pathway.
Area of Science:
- Hepatology
- Molecular Biology
- Metabolic Diseases
Background:
- Autophagy is crucial in nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC).
- Protein tyrosine phosphatase receptor type O (PTPRO) is a known tumor suppressor, but its role in NASH is unclear.
- Investigating PTPRO's role in NASH pathogenesis is essential.
Purpose of the Study:
- To elucidate the role of PTPRO-dependent autophagy in insulin resistance, lipid metabolism, and hepatocarcinogenesis.
- To understand the molecular mechanisms linking PTPRO, autophagy, and NASH progression.
Main Methods:
- Utilized wild-type and ptpro-/- mice fed a high-fat diet (HFD) post-diethylnitrosamine (DEN) injection to model NASH.
- Analyzed liver injury, insulin resistance, hepatosteatosis, autophagy markers, gene expression (lipogenesis, β-oxidation), and protein levels (AKT, p53, MDMX/MDM2).
- Examined PTPRO expression and p62 accumulation in human steatohepatitis samples.
Main Results:
- Ptpro-/- mice showed severe liver injury, insulin resistance, hepatosteatosis, and autophagy deficiency compared to WT mice.
- PTPRO deletion promoted lipogenic genes, reduced β-oxidation genes, and increased AKT activation and cytoplasmic p53 accumulation, repressing autophagy.
- Hyperinsulinemia was exacerbated in HFD-fed ptpro-/- mice; AKT activation stabilized MDMX/MDM2, promoting p53 accumulation, while AKT inhibition restored autophagy.
Conclusions:
- PTPRO regulates insulin and lipid metabolism via the PI3K/Akt/MDM4/MDM2/P53 axis, impacting autophagy.
- PTPRO deficiency exacerbates HFD-induced steatohepatitis due to hyperinsulinemia and autophagy deficiency.
- Decreased PTPRO expression in human NASH correlates with increased p62, highlighting PTPRO's critical role in liver health.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Abnormal Proliferation
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...

